Clinical Encounter QualityNCT06491797
Booster of the "More Time for Patients" Program
A study testing Immediate reactivation in people with Clinical Encounter Quality, run by University Hospital, Geneva at 1 site in Switzerland.
Trial summary
The goal of this clinical trial is to determine if reactivating a hospital program called "Plus de temps au service des patients" (PTP) can improve the quality of pain management for patients and increase job satisfaction among healthcare professionals. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Clinical Encounter Quality
- What is being tested?
- Immediate reactivation
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 764 participants
- Where
- 1 siteSwitzerland
- Study dates
- 1 Aug 2024to 1 Oct 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Implementation of PTP finished at least 6 months previously
- Agreement to the study from both medical head of service and head of unit (IRES)
- Healthcare professionals >18 yo.
- Healthcare professionals working in a HUG service of medicine or surgery.
- Healthcare professionals include Physicians, Nurses, Assistant Nurses, Pharmacists, Physiotherapists and other physical therapists.
- Provided general informed consent.
- Patients hospitalised in one of the boosted units.
- Cognitive ability to provide satisfaction assessment.
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country.
Switzerland1 site
Geneva University Hospitals
Geneva, 1205
Thomas Agoritsas, MD,PhD, 0041 79 553 45 43, thomas.agoritsas@hug.ch
Delphine S. Courvoisier, PhD, 0041 79 553 11 41, delphine.courvoisier@hug.ch
About this study
Official title: Booster of the "More Time for Patients" Program: a Cluster Randomized Controlled Trial
The goal of this clinical trial is to determine if reactivating a hospital program called "Plus de temps au service des patients" (PTP) can improve the quality of pain management for patients and increase job satisfaction among healthcare professionals. The main questions this study aims to answer are:
- Does reactivating PTP improve the quality of pain management?
- Does reactivating PTP increase healthcare professionals' job satisfaction? In this study, researchers will compare the effects of reactivating the program immediately to reactivating it after a 3-month delay.
Read more
Participants in the trial are healthcare professionals who will:
- Select 2 or 3 elements of the program they believe would be most beneficial to reactivate in their hospital units.
- Implement the selected elements for 3 months.
- Complete job satisfaction and burnout questionnaires before and after the study.
- Conditions
- Clinical Encounter Quality
- Being tested
- Immediate reactivation
- Keywords
- Health Care Quality, Access and Evaluation, Patient satisfaction, Job satisfaction, Inpatients, Pain Management
- Medical subject headings
- Patient Satisfaction, Agnosia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Immediate reactivationBehavioural
Our intervention will be booster measure of the existing PTP elements that will be designed for each unit that has been randomized to the immediate intervention group. The booster will consist in a reactivation through audit and feedback of 2-3 elements of the PTP program. The selection of the elements to boost will be done locally in each unit through a coordinated discussion between representants of the PTP organization and representants of the unit's medical and nursing professionals. This will create an adaptable intervention that will feature selected standards among the list of 36 existing standards. The boost will be performed over 3 months
| Study group | Role | What they receive |
|---|---|---|
| Immediate reactivation | Experimental | Our intervention will be booster measure of the existing PTP elements that will be designed for each unit that has been randomized to the immediate intervention group. The booster will consist in a reactivation through audit and feedback of 2-3 elements of the PTP program. The selection of the elements to boost will be done locally in each unit through a coordinated discussion between representants of the PTP organization and representants of the unit's medical and nursing professionals. This will create an adaptable intervention that will feature selected standards among the list of 36 existing standards. The boost will be performed over 3 months Receives: Behavioral: Immediate reactivation |
| Delayed reactivation | No intervention | The control intervention will also be PTP as applied usually, in the control group before the application of the booster measure (applied delayed by three months). |
What is being measured
The primary outcome is the main question the study is designed to answer.
Timely delivery of appropriate analgesic
Quality of pain management as recorded through the timely delivery of an appropriate level painkiller after any pain Visual Analog Scale (VAS) ≥4. VAS score range from 0 to 10, 0 being no pain and 10 being the worse pain imaginable.
Measured: Timely is operationalized as maximum 6 hours before for reserve pain medication, and up to 1 hour after pain measurement for any medication appropriate to the level of pain.
Secondary outcomes (7)
Pain VAS documentation
Patients stay will be divided in 12 hours segments and documentation will be considered adequate when 90% of the segments have at least 1 pain Visual Analog Scale score documented. VAS score range from 0 to 10, 0 being no pain and 10 being the worse pain imaginable.
Measured: 12 hours
Patient satisfaction - Picker
Patient satisfaction is already routinely collected via continuous Picker satisfaction questionnaires. They are sent one week after patient discharge to all patients with a valid email address.
Measured: 1 week after discharge for every patients.
Patient satisfaction - daily
Daily patient satisfaction is already routinely collected in a 3 level scale going from 1 dissatisfied to 3 fully satisfied. Surveys are realized at the bedside, often by nurse assistant in the early afternoon.
Measured: Every day from month 1 to month 3 corresponding to the period of study
Healthcare professionals' satisfaction
Healthcare professionals' satisfaction will be evaluated using the satisfaction with work scale. All item range from extremely dissatisfied to extremely satisfied.
Measured: Once before the reactivation and once after (month 1 and month 3)
Healthcare professionals' burnout
Burnout will be assessed using the Copenhagen burnout inventory. The Copenhagen Burnout Inventory is a three dimensions scale evaluating the personal, the professional and the relational components of burnout. Each dimension is scored on a scale ranging from 0 to 100, 0 being no burnout and 100 being the maximum burnout.
Measured: Once before the reactivation and once after (month 1 and month 3)
Healthcare professionals' risk of turnover
Risk of turnover will be investigated by the following validated single item "If it were possible and you would keep a similar salary, would you like to change profession to take up another one or to keep the same profession but without patient care?" Three answers are possible: "No, I do not want to", "Perhaps", and "Yes, I do want to"
Measured: Once before the reactivation and once after (month 1 and month 3)
Healthcare professional's absenteeism rate
If given consent by the participants, individual monthly absenteeism rate will be extracted from the human resources of the hospital. For all others, absenteeism rate will be extracted aggergated at the unit level.
Measured: At month 1, 2 and 3 corresponding to the period of study
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Jul 2024
- Study start1 Aug 2024 (estimated)
- Primary completion1 Mar 2025 (estimated)
- Study completion1 Oct 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Clinical Encounter QualityStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Intervention group will see immediate reactivation of the program where control intervention will be the program as it is usually applied before the application of the booster measure (applied delayed by three months).
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 764 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Geneva
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Thomas Agoritsas, University Hospital, Geneva
- Investigators
- Thomas Agoritsas, MD, PhD, Principal investigator, University Hospital, GenevaDelphine S. Courvoisier, PhD, Principal investigator, University Hospital, Geneva
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06491797
- Sponsor's protocol ID
- PTPBooster
- Status last verified
- Jul 2024
- First submitted
- 6 Jun 2024
- Last updated
- 9 Jul 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Buclin CP, Burgisser N, Mongin D, Le Mauguen A, Farhoumand PD, Berner A, Daverio JE, Barrios J, Reny JL, Courvoisier DS, Agoritsas T. Impact of a booster intervention of the 'More Time at Patients' Side' programme on patients and healthcare professionals in a Swiss hospital: protocol for a cluster randomised controlled trial. BMJ Open. 2026 Jan 13;16(1):e104027. doi: 10.1136/bmjopen-2025-104027.
PubMed 41529885
Study at a glance
From the registry record, last updated by the sponsor on 9 Jul 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Booster of the "More Time for Patients" Program: a Cluster Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT06491797
- Acronym / sponsor ID
- PTPBooster
- Conditions
- Clinical Encounter Quality
- Keywords
- Health Care Quality, Access and Evaluation, Patient satisfaction, Job satisfaction, Inpatients, Pain Management
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 764 participants (estimated)
- Lead sponsor
- University Hospital, GenevaUniversity, hospital or other
- Study start
- 1 Aug 2024 (estimated)
- Primary completion
- 1 Mar 2025 (estimated)
- Study completion
- 1 Oct 2025 (estimated)
- First posted
- 9 Jul 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to determine if reactivating a hospital program called "Plus de temps au service des patients" (PTP) can improve the quality of pain management for patients and increase job satisfaction among healthcare professionals. The main questions this study aims to answer are:
- Does reactivating PTP improve the quality of pain management?
- Does reactivating PTP increase healthcare professionals' job satisfaction? In this study, researchers will compare the effects of reactivating the program immediately to reactivating it after a 3-month delay.
Participants in the trial are healthcare professionals who will:
- Select 2 or 3 elements of the program they believe would be most beneficial to reactivate in their hospital units.
- Implement the selected elements for 3 months.
- Complete job satisfaction and burnout questionnaires before and after the study.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
- Model description
- Intervention group will see immediate reactivation of the program where control intervention will be the program as it is usually applied before the application of the booster measure (applied delayed by three months).
| Arm | Type | Receives |
|---|---|---|
| Immediate reactivation | Experimental | Behavioral: Immediate reactivationOur intervention will be booster measure of the existing PTP elements that will be designed for each unit that has been randomized to the immediate intervention group. The booster will consist in a reactivation through audit and feedback of 2-3 elements of the PTP program. The selection of the elements to boost will be done locally in each unit through a coordinated discussion between representants of the PTP organization and representants of the unit's medical and nursing professionals. This will create an adaptable intervention that will feature selected standards among the list of 36 existing standards. The boost will be performed over 3 months |
| Delayed reactivation | No intervention | –The control intervention will also be PTP as applied usually, in the control group before the application of the booster measure (applied delayed by three months). |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (8 listed)
- Implementation of PTP finished at least 6 months previously
- Agreement to the study from both medical head of service and head of unit (IRES)
- Healthcare professionals >18 yo.
- Healthcare professionals working in a HUG service of medicine or surgery.
- Healthcare professionals include Physicians, Nurses, Assistant Nurses, Pharmacists, Physiotherapists and other physical therapists.
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Immediate reactivationOur intervention will be booster measure of the existing PTP elements that will be designed for each unit that has been randomized to the immediate intervention group. The booster will consist in a reactivation through audit and feedback of 2-3 elements of the PTP program. The selection of the elements to boost will be done locally in each unit through a coordinated discussion between representants of the PTP organization and representants of the unit's medical and nursing professionals. This will create an adaptable intervention that will feature selected standards among the list of 36 existing standards. The boost will be performed over 3 months | Behavioural | Immediate reactivation |
Primary outcome
Timely delivery of appropriate analgesic
Time frame: Timely is operationalized as maximum 6 hours before for reserve pain medication, and up to 1 hour after pain measurement for any medication appropriate to the level of pain.
Quality of pain management as recorded through the timely delivery of an appropriate level painkiller after any pain Visual Analog Scale (VAS) ≥4. VAS score range from 0 to 10, 0 being no pain and 10 being the worse pain imaginable.
7 secondary outcomes
Pain VAS documentation
Time frame: 12 hours
Patient satisfaction - Picker
Time frame: 1 week after discharge for every patients.
Patient satisfaction - daily
Time frame: Every day from month 1 to month 3 corresponding to the period of study
Healthcare professionals' satisfaction
Time frame: Once before the reactivation and once after (month 1 and month 3)
Healthcare professionals' burnout
Time frame: Once before the reactivation and once after (month 1 and month 3)
Healthcare professionals' risk of turnover
Time frame: Once before the reactivation and once after (month 1 and month 3)
Healthcare professional's absenteeism rate
Time frame: At month 1, 2 and 3 corresponding to the period of study
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Jul 2024.
- Derived from this study: PubMed 41529885Buclin CP, Burgisser N, Mongin D, Le Mauguen A, Farhoumand PD, Berner A, Daverio JE, Barrios J, Reny JL, Courvoisier DS, Agoritsas T. Impact of a booster intervention of the 'More Time at Patients' Side' programme on patients and healthcare professionals in a Swiss hospital: protocol for a cluster randomised controlled trial. BMJ Open. 2026 Jan 13;16(1):e104027. doi: 10.1136/bmjopen-2025-104027.
- Individual participant dataSharing planned: No
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Thomas Agoritsas, MD, PhD principal investigator
University Hospital, Geneva
Delphine S. Courvoisier, PhD principal investigator
University Hospital, Geneva
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Immediate reactivation in people with Clinical Encounter Quality, run by University Hospital, Geneva at 1 site in Switzerland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 9 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Thomas Agoritsas, MD, PhD (0041 79 553 45 43, thomas.agoritsas@hug.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Timely delivery of appropriate analgesic (time frame: Timely is operationalized as maximum 6 hours before for reserve pain medication, and up to 1 hour after pain measurement for any medication appropriate to the level of pain.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06491797, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jul 2024; AzTrials last refreshed its copy on 1 Nov 2026.